Sanders Capital PG trades
Lewis Sanders
Lewis Sanders Procter & Gamble Company stake
total: 133
Trades details
- Total transactions:
- 22
- New positions:
- 1
- Sold out:
- 1
- Added:
- 10
- Reduced:
- 10
- Held since:
- 2021 Q2
- Held for:
- 21 quarters
- Latest activity:
- 2026 Q3
According to 2026 Q3 report, Lewis Sanders doesn't hold any Procter & Gamble Company (PG) shares. To date, the estimated cost basis is nearly $141.42 for "buy" trades and estimated average "sell" price is $147.93. Sanders Capital first purchased PG in 2021 Q2, initially acquiring about 6.59M shares. Since the initial investment in Procter & Gamble Company (PG), Sanders Capital has made 21 more transactions.
When did Lewis Sanders sell Procter & Gamble Company (PG)?
Lewis Sanders sold off the entire Procter & Gamble Company (PG) position in 2026 Q3.
When did Lewis Sanders buy Procter & Gamble Company (PG)?
Lewis Sanders first invested in Procter & Gamble Company (PG) in 2021 Q2 at the reported quarter-end price of $134.93 per share.
What's the cost basis of Sanders Capital's PG stake?
The estimated cost basis for Procter & Gamble Company (PG) stake is around $141.42 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $141.42
- Weighted AVG sell price:
- $147.93
Lewis Sanders's historical trades in Procter & Gamble Company
22 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q3
|
0.00%
|
0
|
$146.64
|
|
-100% (-6,648,957)
|
-0.98%
|
|
2026 Q2
|
0.98%
|
6,648,957
|
$146.64
|
$975,003,054
|
-1.52% (-102,531)
|
-0.02%
|
|
2026 Q1
|
1.16%
|
6,751,488
|
$144.44
|
$975,184,927
|
-0.36% (-24,198)
|
-0%
|
|
2025 Q4
|
1.12%
|
6,775,686
|
$143.31
|
$971,023,561
|
-0.50% (-34,283)
|
-0.01%
|
|
2025 Q3
|
1.29%
|
6,809,969
|
$153.65
|
$1,046,351,737
|
-3.59% (-253,890)
|
-0.05%
|
|
2025 Q2
|
1.51%
|
7,063,859
|
$159.32
|
$1,125,414,016
|
-3.20% (-233,243)
|
-0.06%
|
|
2025 Q1
|
1.86%
|
7,297,102
|
$170.42
|
$1,243,572,123
|
-0.77% (-56,613)
|
-0.01%
|
|
2024 Q4
|
1.80%
|
7,353,715
|
$167.65
|
$1,232,850,320
|
+1.44% (+104,168)
|
+0.03%
|
|
2024 Q3
|
1.82%
|
7,249,547
|
$173.20
|
$1,255,621,540
|
+1.24% (+88,649)
|
+0.02%
|
|
2024 Q2
|
1.81%
|
7,160,898
|
$164.92
|
$1,180,975,298
|
+1.40% (+98,711)
|
+0.02%
|
|
2024 Q1
|
1.91%
|
$162.25
|
+1.07% (+74,679)
|
|||
|
2023 Q4
|
1.89%
|
$146.54
|
+3.31% (+223,798)
|
|||
|
2023 Q3
|
2.08%
|
$145.86
|
+0.24% (+16,459)
|
|||
|
2023 Q2
|
2.14%
|
$151.74
|
-0.11% (-7,199)
|
|||
|
2023 Q1
|
2.38%
|
$148.69
|
-13.39% (-1,044,117)
|
|||
|
2022 Q4
|
3.10%
|
$151.56
|
-9.28% (-797,645)
|
|||
|
2022 Q3
|
2.98%
|
$126.25
|
+1.79% (+150,929)
|
|||
|
2022 Q2
|
3.07%
|
$143.79
|
-0.37% (-31,020)
|
|||
|
2022 Q1
|
2.82%
|
$152.80
|
+0.93% (+77,920)
|
|||
|
2021 Q4
|
2.80%
|
$163.58
|
+22.31% (+1,532,184)
|
|||
|
2021 Q3
|
2.18%
|
$139.80
|
+4.24% (+279,310)
|
|||
|
2021 Q2
|
2.02%
|
$134.93
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.